Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transplantation of Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation or Cyclophosphamide/Fludarabine/Thiotepa/Total Body Irradiation Myeloablative Preparative Regimen

NCT00719888 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT00719888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00719888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transplantation of Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation or Cyclophosphamide/Fludarabine/Thiotepa/Total Body Irradiation Myeloablative Preparative Regimen
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2005
Completion date
December 19, 2024
Enrollment
135 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, burkitt lymphoma, chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, chronic phase chronic myelogenous leukemia, bcr-abl1 positive, follicular lymphoma, lymphoblastic lymphoma, lymphoplasmacytic lymphoma, mantle cell lymphoma, marginal zone lymphoma, myelodysplastic syndrome, myelofibrosis, non-hodgkin lymphoma, plasma cell myeloma, prolymphocytic leukemia, refractory anemia, small lymphocytic lymphoma